Recently, health chiefs proclaimed that NHS would not fund cancer treatment anymore in England. The public funded health agency used to fund twenty five different kinds of cancer treatment.
A short time ago, the health care system has spent £280 m on Cancer Drug Funds. Hence, NHS went £100m over budget in 2014. The large amount of money compels NHS to take this step.
The announcement has raised several questions in the minds of high officials. Currently, people are worried how NHS would pay for innovative new drugs in future.
The National Institute for Health and Care Excellence (NICE) approves the extensive use of drugs in NHS. From now onwards, NHS would limit the list of drugs which would certainly affect the health of patients. The new rule would be implemented from 12th of March. It is expected to affect the treatments of some deadly diseases such as bowel cancer, breast cancer, pancreatic cancer.
The treatment of advance bowel cancer is extremely popular among the patients. It is commonly known as Avastin bowel cancer treatment. As per the reports of The Rarer Cancers Foundation, the new rule will take the facilities of treatment from approximately 7,700 patients.
However, the agency declared that it will fund the treatment of cancer patients who are presently under treatment.
